Ftse Mib
36.434,15
0,17%
DAX
21.727,20
0,48%
S&P 500
6.049,76
0,17%
NASDAQ
19.571,29
-0,31%
Bitcoin
105.146,24
1,36%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Esperion Therapeutics Inc (ESPR) Esperion Therapeutics Inc (ESPR) Notizie

Esperion Therapeutics Inc

ESPR
1,888
-0,002 (-0,11%)
Ultimo aggiornamento: 18:33:07
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/1/202522:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/1/202522:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202521:30EDGAR2Form 144 - Report of proposed sale of securities
17/1/202521:17EDGAR2Form 144 - Report of proposed sale of securities
16/1/202514:40EDGAR2Form 8-K - Current report
09/1/202514:00GLOBEEsperion to Host Virtual Key Opinion Leader Event on..
02/1/202514:00GLOBEEsperion to Participate in Upcoming 43rd Annual J.P. Morgan..
18/12/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202413:10EDGAR2Form 8-K - Current report
18/12/202413:00GLOBEEsperion Strengthens Balance Sheet with Closing of..
17/12/202421:46EDGAR2Form 144 - Report of proposed sale of securities
17/12/202421:22EDGAR2Form 144 - Report of proposed sale of securities
17/12/202421:21EDGAR2Form 144 - Report of proposed sale of securities
13/12/202412:43EDGAR2Form 8-K - Current report
13/12/202412:00GLOBEEsperion Announces $210 Million Convertible Debt Financing
12/12/202414:00GLOBEEsperion Partners with Neopharm to Commercialize NEXLETOL®..
02/12/202414:00GLOBEEsperion Announces New Drug Submissions in Canada for..
26/11/202414:00GLOBEOtsuka Submits New Drug Application in Japan for Bempedoic..
21/11/202414:00GLOBEEsperion to Participate in Upcoming Piper Sandler 36th..
20/11/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202422:07EDGAR2Form 144 - Report of proposed sale of securities
18/11/202416:30GLOBEEsperion Highlights New Exploratory Data from CLEAR Outcomes..
14/11/202414:42EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202422:15GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
07/11/202422:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:22EDGAR2Form 8-K - Current report
07/11/202412:19IHMARKETNEWSU.S. Futures Rise as Investors Await Fed Rate Decision; Oil..
07/11/202412:00GLOBEEsperion Reports Third Quarter 2024 Financial Results and..
04/11/202414:00GLOBEEsperion to Participate in Upcoming Jefferies London..
31/10/202413:00GLOBEEsperion Announces a Featured Presentation in the Late..
24/10/202414:00GLOBEEsperion to Report Third Quarter 2024 Financial Results on..
23/10/202400:06EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
18/10/202422:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202421:25EDGAR2Form 144 - Report of proposed sale of securities
02/10/202414:00GLOBEEsperion EU Partner Reports Final Real-World Results from..
25/9/202422:30GLOBEEsperion Announces Inducement Grant Under NASDAQ Listing..
18/9/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202422:02EDGAR2Form 144 - Report of proposed sale of securities
17/9/202421:28EDGAR2Form 144 - Report of proposed sale of securities
17/9/202421:20EDGAR2Form 144 - Report of proposed sale of securities
05/9/202414:00GLOBEEsperion to Participate in Upcoming 2024 Cantor Global..
03/9/202414:00GLOBEEsperion Secures Additional Commercial and Medicare..
26/8/202414:00GLOBEEsperion to Participate in Upcoming H.C. Wainwright 26th..
20/8/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/8/202421:50EDGAR2Form 144 - Report of proposed sale of securities
12/8/202422:33EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/8/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 1,88 Min: 1,86 Max: 1,90
Chiusura: 1,89

La tua Cronologia

NASDAQ
ESPR
Esperion Therapeutics
NYSE
CGAU
Centerra Gold
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci